🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the efficacy and safety of dasotraline in children 6 to...
Status
Completed
Location
Avida Inc
Start Date
2017-07-31
Trial ID
NCT03231800
Treatments Being Tested
Study of the what the body does to the drug in subjects with mild, moderate...
Status
Completed
Location
Clinical Pharmacology of Miami, Inc.
Start Date
2016-05
Trial ID
NCT02795637
Treatments Being Tested
Binge Eating Disorder Extension Study....
Status
Completed
Location
Noesis Parma
Start Date
2016-02-29
Trial ID
NCT02684279
Treatments Being Tested
This is a 6 week efficacy and safety study of Dasotraline in subjects 6 to ...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2015-04
Trial ID
NCT02428088
Treatments Being Tested
A study to evaluate a drug (dasotraline) on the safety, effectiveness and h...
Status
Completed
Location
NoesisPharma, LLC
Start Date
2017-03-31
Trial ID
NCT03107026
Treatments Being Tested
Evaluate the efficacy of flexibly-dosed dasotraline compared with placebo i...
Status
Completed
Location
Southern California Research
Start Date
2015-10
Trial ID
NCT02564588
Treatments Being Tested
Pediatric PK study of SEP-225289 (Dasotraline)...
Status
Completed
Location
Woodland International Research Group
Start Date
2014-07
Trial ID
NCT02195167
Treatments Being Tested
This is a randomized, double blind, multicenter, parallel group, outpatient...
Status
Completed
Location
NoesisPharma,LLC
Start Date
2014-12
Trial ID
NCT02276209
Treatments Being Tested
This is an open label 26 week extension study for subjects who completed SE...
Status
Completed
Location
Harmonex Neuroscience Research, Inc
Start Date
2015-06-30
Trial ID
NCT02457819
Treatments Being Tested
A Phase 2 study of SEP-225289 in adults with attention deficit hyperactivit...
Status
Completed
Location
Pharmacology Research Institute
Start Date
2012-12
Trial ID
NCT01692782
Treatments Being Tested